Patient preferences and perspectives regarding reducing alcohol consumption: Role of nalmefene

Patient Preference and Adherence

Volumn 8, Issue , 2014, Pages 1347-1352

  Luquiens, Amandine ^a   Aubin, Henri Jean ^a  

^a Universite Paris Sud   (France)

Author keywords

Alcohol use disorder; Harm reduction; Patients satisfaction; Therapeutic goal

Indexed keywords

NALMEFENE; PLACEBO;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ALCOHOLISM; DIZZINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; HARM REDUCTION; HEADACHE; HEALTH CARE ACCESS; HEALTH CARE NEED; HUMAN; MOTIVATIONAL INTERVIEWING; NAUSEA; PATIENT ATTITUDE; PATIENT CARE; PATIENT PREFERENCE; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84908130959     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S57358     Document Type: Review

References (47)

1. Roerecke M, Rehm J. Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction. 2013;108(9):1562-1578.
2. Rehm J, Shield KD. Global alcohol-attributable deaths from cancer, liver cirrhosis, and injury in 2010. Alcohol Res. 2013;35(2):174-183.
3. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373(9682):2223-2233.
4. Kohn R, Saxena S, Levav I, Saraceno B. The treatment gap in mental health care. Bull World Health Organ. 2004;82(11):858-866.
5. Dawson DA, Grant BF, Stinson FS, Chou PS, Huang B, Ruan WJ. Recovery from DSM-IV alcohol dependence: United States, 2001-2002. Addiction. 2005;100(3):281-292.
6. Stuart H. The stigmatization of mental illnesses. Can J Psychiatry. 2012;57(8):455-456.
7. SAMHSA. Results from the 2011 National Survey on Drug Use and Health: Mental Health Findings: U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality, 2012 November 2012. Available from: http://www.samhsa.gov/data/NSDUH/2k11MH_FindingsandDetTables/2K11MHFR/NSDUHmhfr2011.htm. Accessed September 18, 2014.
8. Luquiens A, Reynaud M, Aubin HJ. Is controlled drinking an acceptable goal in the treatment of alcohol dependence? A survey of French alcohol specialists. Alcohol Alcohol. 2011;46(5):586-591.
9. Heather N, Adamson SJ, Raistrick D, Slegg GP; UKATT Research Team. Initial preference for drinking goal in the treatment of alcohol problems: I. Baseline differences between abstinence and non-abstinence groups. Alcohol Alcohol. 2010;45(2):128-135.
10. EMA-CHMP. Selincro Assessment report, December 13, 2012. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002583/WC500140326.pdf. Accessed September 23, 2014.
11. Adamson SJ, Heather N, Morton V, Raistrick D; UKATT Research Team. Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes. Alcohol Alcohol. 2010;45(2):136-142.
12. Miller WR. Motivation for treatment: a review with special emphasis on alcoholism. Psychol Bull. 1985;98(1):84-107.
13. McQueen J, Howe TE, Allan L, Mains D, Hardy V. Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane Database Syst Rev. 2011;(8):CD005191.
14. Sheldon K, Williams G, Joiner T. Self-determination Theory. 2003.
15. Rinn W, Desai N, Rosenblatt H, Gastfriend DR. Addiction denial and cognitive dysfunction: a preliminary investigation. J Neuropsychiatry Clin Neurosci. 2002;14(1):52-57.
16. Blume AW, Schmaling KB, Marlatt GA. Memory, executive cognitive function, and readiness to change drinking behavior. Addict Behav. 2005;30(2):301-314.
17. Dawson DA, Goldstein RB, Grant BF. Differences in the profiles of DSM-IV and DSM-5 alcohol use disorders: implications for clinicians. Alcohol Clin Exp Res. 2013;37 Suppl 1:E305-E313.
18. American Psychiatric Association. Substance-related and addictive disorders fact sheet. Arlington: American Psychiatric Association; 2013. Available from: http://www.dsm5.org/Documents/Substance%20Use%20Disorder%20Fact%20Sheet.pdf. Accessed 2013.
19. DeMartini KS, Devine EG, DiClemente CC, Martin DJ, Ray LA, O'Malley SS. Predictors of pretreatment commitment to abstinence: results from the COMBINE study. J Stud Alcohol Drugs. 2014; 75(3):438-446.
20. Canguilhem G, Fawcett CR (translator). The Normal and the Pathological. New York: Zone Books; 1991.
21. Mumu SJ, Saleh F, Ara F, Afnan F, Ali L. Non-adherence to life-style modification and its factors among type 2 diabetic patients. Indian J Public Health. 2014;58(1):40-44.
22. Wallhed Finn S, Bakshi AS, Andreasson S. Alcohol consumption, dependence, and treatment barriers: perceptions among nontreatment seekers with alcohol dependence. Subst Use Misuse. 2014;49(6): 762-769.
23. Wilcox CE, Dekonenko CJ, Mayer AR, Bogenschutz MP, Turner JA. Cognitive control in alcohol use disorder: deficits and clinical relevance. Rev Neurosci. 2014;25(1):1-24.
24. EMA. Guideline on the development of medicinal products for the treatment of alcohol dependence: European Medicines Agency, 2010 18 February. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/03/WC500074898.pdf. Accessed September 18, 2014.
25. Sobell LC, Sobell MB, Connors GJ, Agrawal S. Assessing drinking outcomes in alcohol treatment efficacy studies: selecting a yardstick of success. Alcohol Clin Exp Res. 2003;27(10):1661-1666.
26. Sawayama T, Yoneda J, Tanaka K, et al. The predictive validity of the Drinking-Related Cognitions Scale in alcohol-dependent patients under abstinence-oriented treatment. Subst Abuse Treat Prev Policy. 2012; 7:17.
27. May J, Andrade J, Kavanagh DJ, et al. The Craving Experience Questionnaire: a brief, theory-based measure of consummatory desire and craving. Addiction. 2014;109(5):728-735.
28. Holla B, Viswanath B, Agarwal SM, et al. Visual Image-Induced Craving for Ethanol (VICE): Development, Validation, and a Pilot fMRI Study. Indian J Psychol Med. 2014;36(2):164-169.
29. Luquiens A, Reynaud M, Falissard B, Aubin HJ. Quality of life among alcohol-dependent patients: How satisfactory are the available instruments? A systematic review. Drug Alcohol Depend. 2012; 125(3):192-202.
30. Zubaran C, Foresti K. Quality of life and substance use: concepts and recent tendencies. Curr Opin Psychiatry. 2009;22(3):281-286.
31. Luquiens A, Whalley D, Crawford R, et al. Développement et validation de l' "Alcohol use disorder Quality Of Life Scale". [Development and validation of the "Alcohol use disorder Quality of Life Scale"]. Oral presentation at the International Congress of Addictology; June 5-6, 2014; Paris. French.
32. Heidbreder CA, Hagan JJ. Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving. Curr Opin Pharmacol. 2005;5(1):107-118.
33. Frick KM, Loessl B, Brueck RK, et al. What works for patients in outpatient treatment for alcohol addiction? An explorative study into clients' evaluation of subjective factors and therapy satisfaction. Subst Abuse. 2011;5:27-34.
34. Donovan DM, Kadden RM, DiClemente CC, Carroll KM. Client satisfaction with three therapies in the treatment of alcohol dependence: results from project MATCH. Am J Addict. 2002;11(4):291-307.
35. van den Brink W, Aubin HJ, Bladström A, Torup L, Gual A, Mann K. Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: results from a subgroup analysis of two randomized controlled 6-month studies. Alcohol Alcohol. 2013;48(5): 570-578.
36. Perestelo-Perez L, Rivero-Santana A, Perez-Ramos J, Gonzalez-Lorenzo M, Roman JG, Serrano-Aguilar P. Shared decision making in Spain: current state and future perspectives. Z Evid Fortbild Qual Gesundhwes. 2011;105(4):289-295.
37. Anton RF, O'Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006; 295(17):2003-2017.
38. Ernst DB, Pettinati HM, Weiss RD, Donovan DM, Longabaugh R. An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care. Ann Fam Med. 2008;6(5):435-440.
39. Nordon C, Falissard B, Gerard S, et al. Patient satisfaction with psychotropic drugs: Validation of the PAtient SAtisfaction with Psychotropic (PASAP) scale in patients with bipolar disorder. Eur Psychiatry. 2014; 29(3):183-190.
40. ANSM. RTU du baclofène dans l'alcoolodépendance, 2014 fevrier [Guidelines for temporary use of baclofene in alcohol dependence, 2014 February]. Available from: http://ansm.sante.fr/var/ansm_site/storage/original/application/5478accaf69e1a0f97987c9eeb9b9347.pdf. Accessed September 18, 2014. French.
41. Groshkova T, Metrebian N, Hallam C, et al. Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics. Drug Alcohol Rev. 2013; 32(6):566-573.
42. European Medicines Agency. Selincro (nalmefene): EU summary of product characteristics. 2013 28 June 2013. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002583/WC500140255.pdf. Accessed September 23, 2014.
43. Gual A, He Y, Torup L, van den Brink W, Mann K; ESENSE 2 Study Group. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. Eur Neuropsychopharmacol. 2013;23(11):1432-1442.
44. Keating GM. Nalmefene: a review of its use in the treatment of alcohol dependence. CNS Drugs. 2013;27(9):761-772.
45. van den Brink W, Sørensen P, Torup L, Mann K, Gual A; for the SENSE Study Group. Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study. J Psychopharmacol. 2014;28(8):733-744.
46. Sinclair J, Chick J, Sørensen P, Kiefer F, Batel P, Gual A. Can Alcohol Dependent Patients Adhere to an 'As-Needed' Medication Regimen? Eur Addict Res. 2014;20(5):209-217.
47. Raistrick D, Heather N, Godfrey C. Review of the effectiveness of treatment for alcohol problems: NHS, National Treatment Agency for Substance Misuse: NHS, National Treatment Agency for Substance Misuse, 2006. Available from: http://www.nta.nhs.uk/uploads/nta_review_of_the_effectiveness_of_treatment_for_alcohol_problems_fullreport_2006_alcohol2.pdf. Accessed September 18, 2014.